Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1516 studies found for:    "Chronic lymphocytic leukemia"
Show Display Options
Rank Status Study
21 Withdrawn Protocol to Obtain Blood for Discovery of Novel Biomarkers and Potential Therapeutic Targets in Chronic Lymphocytic Leukemia
Condition: Chronic Lymphocytic Leukemia
Intervention: Other: No Intervention
22 Active, not recruiting Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Condition: Chronic Lymphocytic Leukemia
Intervention:
23 Completed Safety and Efficacy of IDEC-152 in the Treatment of Chronic Lymphocytic Leukemia (CLL)
Condition: Chronic Lymphocytic Leukemia
Intervention: Drug: IDEC-152
24 Completed Lenalidomide in Chronic Lymphocytic Leukemia (CLL) Patients With Residual Disease
Condition: Chronic Lymphocytic Leukemia
Intervention: Drug: Lenalidomide
25 Recruiting Identification of Biomarkers That Are Predictive of Early Ibrutinib Treatment Failure in High Risk TP53 Mutated Chronic Lymphocytic Leukemia
Condition: Chronic Lymphocytic Leukemia
Intervention: Drug: Ibrutinib
26 Terminated Safety and Efficacy of SDX-101 (R-Etodolac) in Combination With Chlorambucil, and That of Chlorambucil Alone, in Patients With Chronic Lymphocytic Leukemia (CLL)
Condition: Chronic Lymphocytic Leukemia
Interventions: Drug: Chlorambucil;   Drug: R-etodolac + chlorambucil
27 Unknown  Allogeneic Stem Cell Transplantation in Chronic Lymphocytic Leukemia
Condition: Chronic Lymphocytic Leukemia
Interventions: Procedure: allogeneic stem cell transplantation;   Drug: Alemtuzumab
28 Completed Lenalidomide, Fludarabine & Cyclophosphamide in Advanced Chronic Lymphocytic Leukemia Not Responding to Therapy
Condition: Chronic Lymphocytic Leukemia
Interventions: Drug: Cyclophosphamide;   Drug: Fludarabine phosphate;   Drug: Lenalidomide
29 Terminated Combination Chemotherapy With or Without G-CSF in Treating Patients With Relapsed Chronic Lymphocytic Leukemia
Condition: Chronic Lymphocytic Leukemia
Interventions: Biological: Filgrastim;   Drug: Fludarabine;   Drug: Cyclophosphamide;   Drug: Mitoxantrone
30 Active, not recruiting A Phase 2 Open-Label Study of the Efficacy and Safety of ABT-199 (GDC-0199) in Chronic Lymphocytic Leukemia (CLL) Subjects With Relapse or Refractory to B-Cell Receptor Signaling Pathway Inhibitor Therapy
Condition: Chronic Lymphocytic Leukemia
Intervention: Drug: ABT-199
31 Terminated Lumiliximab With Fludarabine, Cyclophosphamide, and Rituximab (FCR) Versus FCR Alone in Subjects With Relapsed Chronic Lymphocytic Leukemia (CLL)
Condition: Chronic Lymphocytic Leukemia
Interventions: Drug: FCR + Lumiliximab;   Drug: FCR
32 Completed Fludarabine or Chlorambucil as First-Line Therapy in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia
Condition: Chronic Lymphocytic Leukemia
Interventions: Drug: Fludarabine;   Drug: Chlorambucil
33 Completed Alemtuzumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia
Condition: Chronic Lymphocytic Leukemia
Interventions: Biological: Alemtuzumab i.v.;   Biological: Alemtuzumab s.c.
34 Withdrawn A Study of Safety and Effectiveness of Bendamustine Hydrochloride in Adult Filipino Patients With Chronic Lymphocytic Leukemia
Condition: Chronic Lymphocytic Leukemia
Intervention: Drug: No intervention
35 Completed Treatment of B-Chronic Lymphocytic Leukemia (B-CLL) With Autologous CD40 Ligand and IL-2-Expressing Tumor Cells
Condition: Chronic Lymphocytic Leukemia (CLL)
Intervention: Biological: CD40 LIGAND AND IL-2-EXPRESSING TUMOR CELLS VACCINE
36 Unknown  Study of Efficacy and Safety of Valproic Acid in Chronic Lymphocytic Leukemia (CLL)
Condition: Chronic Lymphocytic Leukemia
Intervention: Drug: Valproic acid
37 Completed Combination Chemotherapy, Total-Body Irradiation, and Alemtuzumab in Treating Patients Undergoing an Autologous Stem Cell Transplant for Stage I, Stage II, Stage III, or Stage IV Chronic Lymphocytic Leukemia
Condition: Chronic Lymphocytic Leukemia
Interventions: Biological: alemtuzumab;   Biological: filgrastim;   Drug: carmustine;   Drug: cyclophosphamide;   Drug: cytarabine;   Drug: dexamethasone;   Drug: etoposide;   Drug: fludarabine phosphate;   Drug: melphalan;   Procedure: autologous bone marrow transplantation;   Procedure: peripheral blood stem cell transplantation;   Radiation: radiation therapy
38 Withdrawn A Phase 2, Single-Arm, Open-Label Study Evaluating the Efficacy and Safety of Single Agent GS 1101 (CAL 101) as Therapy for Previously Treated Chronic Lymphocytic Leukemia
Condition: Chronic Lymphocytic Leukemia
Intervention: Drug: GS-1101
39 Completed Ofatumumab Added to Dexamethasone in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia
Condition: Chronic Lymphocytic Leukemia
Intervention: Drug: ofatumumab plus dexamethasone
40 Unknown  Trial of FFP+HDMP+Rituximab for Ultra-high Risk Chronic Lymphocytic Leukemia
Condition: Chronic Lymphocytic Leukemia
Intervention: Drug: FFP+HDMP+Rituximab

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.